ロード中...
Metabolic reprogramming of myeloid-derived suppressor cells (MDSC) in cancer
MDSC undergo metabolic reprogramming in the tumor resulting in an increased fatty acid β oxidation that supports their immunosuppressive functions. Fatty acid oxidation inhibitors, used to treat coronary disease, significantly delayed tumor growth and had a significantly increased antitumor effect w...
保存先:
| 出版年: | Oncoimmunology |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5007951/ https://ncbi.nlm.nih.gov/pubmed/27622069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1200771 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|